olmesartan medoxomil has been researched along with Hypertrophy, Right Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akimoto, K; Harasawa, H; Hirata, H; Kaneko, H; Kaneko, N; Nakamoto, T; Sorimachi, K | 1 |
| Ikeda, M; Ito, K; Ito, KM; Kato, T; Nasu, T; Sonoda, H | 1 |
2 other study(ies) available for olmesartan medoxomil and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Effects of olmesartan medoxomil as an angiotensin II-receptor blocker in chronic hypoxic rats.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Collagen; Disease Models, Animal; Echocardiography; Endothelins; Heart; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Imidazoles; Lung; Male; Myocardium; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Pulmonary Artery; Pulmonary Heart Disease; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta | 2005 |
Evaluation of olmesartan medoxomil in the rat monocrotaline model of pulmonary hypertension.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Imidazoles; Lung; Male; Monocrotaline; Olmesartan Medoxomil; Pulmonary Artery; Rats; Rats, Wistar; Tetrazoles; Time Factors | 2008 |